Chelators in the Treatment of Iron Accumulation in Parkinson's Disease

by Ross B. Mounsey, Peter Teismann
Published 2012-01-01

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

by Ross B. Mounsey, Peter Teismann
Published 2011-01-01

S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal Inflammation.

by Jennifer Niven, Joseph Hoare, Debbie McGowan, Gayathri Devarajan, Shigeyoshi Itohara, Monique Gannagé, Peter Teismann, Isabel Crane
Published 2015-01-01

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated...

by Matteo Santoro, Walter Maetzler, Petros Stathakos, Heather L. Martin, Markus A. Hobert, Tim W. Rattay, Thomas Gasser, John V. Forrester, Daniela Berg, Kevin J. Tracey, Gernot Riedel, Peter Teismann
Published 2016-07-01

Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages

by Silke Nuber, Elisabeth Petrasch-Parwez, Oscar Arias-Carrión, Leanie Koch, Zacharias Kohl, Jacqueline Schneider, Carsten Calaminus, Rolf Dermietzel, Anna Samarina, Jana Boy, Huu P. Nguyen, Peter Teismann, Thirumalaisamy Palanichamy Velavan, Philipp J. Kahle, Stephan von Hörsten, Markus Fendt, Rejko Krüger, Olaf Riess
Published 2011-11-01